Model Transparency and Validation

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Medical decision making

• Publication date

  2012-09-01

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1177/0272989X12454579PMID 22990088
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting.

  2013cited by this paper
• Dynamic Transmission Modeling

  2012cited by this paper
• Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6.

  2012cited by this paper
• State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3.

  2012cited by this paper
• Modeling Using Discrete Event Simulation

  2012cited by this paper
• Modeling Good Research Practices—Overview

  2012cited by this paper
• Shining Light into Black Boxes

  2012cited by this paper
• Model Parameter Estimation and Uncertainty Analysis

  2012cited by this paper
• Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.

  2012cited by this paper
• State-Transition Modeling

  2012cited by this paper
• Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5

  2012cited by this paper
• International Society for Pharmacoeconomics and Outcomes Research

  2012cited by this paper
• Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2.

  2012cited by this paper
• Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines

  2012cited by this paper
• Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment

  2012cited by this paper
• Reproducible Research in Computational Science

  2011cited by this paper
• The importance of independent academic statistical analysis.

  2010cited by this paper
• Empirically evaluating decision-analytic models.

  2010cited by this paper
• Disclose all data in publications.

  2010cited by this paper
• Validation of population-based disease simulation models: a review of concepts and methods

  2010cited by this paper
• Reproducible research and the substantive context.

  2010cited by this paper
• The wider concept of data sharing: view from the BMJ.

  2010cited by this paper
• Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis.

  2010cited by this paper
• Health Technology Assessment: Development and Future

  2009cited by this paper
• When to start antiretroviral therapy in resource-limited settings.

  2009cited by this paper
• Reproducible research and Biostatistics.

  2009cited by this paper
• Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force

  2008cited by this paper
• Validation of Prediction of Diabetes by the Archimedes Model and Comparison With Other Predicting Models

  2008cited by this paper
• Computer Modeling of Diabetes and Its Complications

  2007cited by this paper
• A review and critique of modelling in prioritising and designing screening programmes.

  2007cited by this paper
• Effects of torcetrapib in patients at high risk for coronary events.

  2007cited by this paper
• Reproducible Research: Moving toward Research the Public Can Really Trust

  2007cited by this paper
• Reproducible epidemiologic research.

  2006cited by this paper
• Effect of screening and adjuvant therapy on mortality from breast cancer.

  2006cited by this paper
• Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.

  2006cited by this paper
• Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

  2005cited by this paper
• Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey

  2005cited by this paper
• Cost-effectiveness of implantable cardioverter-defibrillators.

  2005cited by this paper
• Analytic Choices in Economic Models of Treatments for Rheumatoid Arthritis: What Makes a Difference?

  2005cited by this paper
• Principles of good modeling practice in healthcare cost-effectiveness studies

  2004cited by this paper
• Optimal search strategies for retrieving systematic reviews from Medline: analytical survey

  2004cited by this paper
• Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system.

  2003cited by this paper
• Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

  2003cited by this paper
• Validation of the archimedes diabetes model.

  2003cited by this paper
• Archimedes: a new model for simulating health care systems--the mathematical formulation

  2002cited by this paper
• Modeling for health care and other policy decisions: uses, roles, and validity.

  2002cited by this paper
• Analytic Tools for Public Health Decision Making

  2002cited by this paper
• Modeling for health care and other policy decisions: uses, roles, and validity.

  2001cited by this paper
• The cost effectiveness of combination antiretroviral therapy for HIV disease.

  2001cited by this paper
• Cost-effectiveness of implantable cardioverter-defibrillators.

  2001cited by this paper
• Use of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-Effectiveness

  2001cited by this paper
• Assessing Quality in Decision Analytic Cost-Effectiveness Models

  2000cited by this paper
• Screening Surgeons for HIV Infection: A Cost-effectiveness Analysis

  1995cited by this paper
• Standardizing Methodologies for Economic Evaluation in Health Care: Practice, Problems, and Potential

  1993cited by this paper
• Simulation for Decision Making

  1993cited by this paper
• Computer Simulation: A Practical Perspective

  1991cited by this paper
• Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model.

  1987cited by this paper
• The frequency of cervical cancer screening. Comparison of a mathematical model with empirical data

  1987cited by this paper
• A guide to simulation (2nd ed.)

  1986cited by this paper
• A guide to simulation

  1983cited by this paper
• Simulation Modeling and Analysis

  1982cited by this paper

• Cost-Effectiveness of Hydroxyurea for Treatment of Children With Sickle Cell Anemia in Ghana.

  2026cites this paper
• Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using a COVID-19 vaccine in Costa Rica.

  2026cites this paper
• Development of the health economic model for type 2 diabetes considering glycaemic variability.

  2026cites this paper
• System dynamics modelling methods for public health policy evaluation: a systematic literature review focussing on mental health and substance use disorders.

  2026cites this paper
• Discrete-Event Simulation Modeling Framework for Cancer Interventions and Population Health in R (DESCIPHR): An Open-Source Pipeline.

  2026cites this paper
• System Preparedness for Rising Kidney Replacement Therapy Demand: Late-Stage CKD Drives Costs, Healthcare Resource Utilisation and Environmental Impact in Switzerland.

  2026cites this paper
• Cost-Effectiveness Analysis of Axillary Management Options at the Time of Contralateral Prophylactic Mastectomy.

  2026cites this paper
• Evidence-based decision analysis guiding clinical guidelines for an organized population-based screening for colorectal cancer.

  2026cites this paper
• Potential Public Health Impact of Updated COVID-19 Vaccination Strategies in Malaysia: Epidemiological Data Update.

  2025cites this paper
• Prophylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in People Living With Severe Hemophilia A : A Cost-Effectiveness Analysis.

  2025cites this paper
• Estimating HIV incidence in Türkiye: results from two mathematical models

  2025cites this paper
• Cost-effectiveness of population-based expanded reproductive carrier screening for genetic diseases in Australia: a microsimulation analysis

  2025cites this paper
• Patient-level simulation models in cancer care: a systematic review

  2025cites this paper
• External Validation of the MicroSimulation Core Obesity Model (MS-COM) to Predict Cardiovascular Outcomes, Mortality and Type 2 Diabetes Mellitus Incidence and Assess Cost Effectiveness

  2025cites this paper
• Perspectives on which health settings geriatricians should staff: a qualitative study of patients, care providers and health administrators

  2025cites this paper
• Modeling the potential public health and economic impact of COVID-19 vaccination strategies using an adapted vaccine in Peru

  2025cites this paper
• Cost-Effectiveness Modelling of Multiple System Atrophy for Early Health Technology Assessment

  2025cites this paper
• Discrete-Event Simulation Model for Cancer Interventions and Population Health in R (DESCIPHR): An Open-Source Pipeline

  2025cites this paper
• Economic evaluation on dental caries preventive interventions for Australian children using a priority-setting approach

  2025cites this paper
• Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in Mexico

  2025cites this paper
• Evaluation of the epidemiological and economic impact of the ADLIFE intervention on medium- to long-term in patients with advanced chronic disease

  2025cites this paper
• Cost-utility and budget impact analysis of desmopressin for treating monosymptomatic nocturnal enuresis in Thai children

  2025cites this paper
• Methodological Approaches for Incorporating Marginalized Populations into HPV Vaccine Modeling: A Systematic Review

  2025cites this paper
• The natural history of ductal carcinoma in situ: development, validation, and estimated outcomes of the SimDCIS model

  2025cites this paper
• A Hemophilia Joint Health Score-Based Model for the Economic Evaluation of Hemophilia A Prophylaxis Interventions

  2025cites this paper
• First-Line Alectinib, Brigatinib, and Lorlatinib for Advanced ALK-Positive Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis.

  2025cites this paper
• Comparing Canada's OncoSim-Breast model with the United States' Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer models.

  2025cites this paper
• Economic evaluation of multiple falls prevention interventions among community-residing older adults: we know the ‘value’, but what about ‘value for money’?

  2025cites this paper
• Systematic Literature Review of Decision‐Analytic Modeling Studies on Nature‐Based Social Prescribing and Loneliness

  2025cites this paper
• Cost-Effectiveness Analyses of Adolescent- and Young-Adult-Focused HIV Interventions Incorporating HIV Transmission: a Scoping Review of Modeling Methods and Proposed Guidance

  2025cites this paper
• Weight Status Transitions and Validation of an Obesity Model for Aboriginal and Torres Strait Islander Children and Adolescents

  2025cites this paper
• The Potential Public Health Impact of the mRNA-Based Respiratory Syncytial Virus Vaccine, mRNA-1345, Under Extended Vaccination Campaigns Among Older Adults in the United Kingdom: A Modelling Study

  2025cites this paper
• Defining Lifetime Risk Thresholds for Breast Cancer Surgical Prevention

  2025cites this paper
• Simulation Modeling of Oral Cancer Development with Risk Stratification: How Potential Screening Programs Can Be Evaluated

  2025cites this paper
• Faithful Narratives from Complex Conceptual Models: Should Modelers or Large Language Models Simplify Causal Maps?

  2025cites this paper
• A Cost-effectiveness Analysis of Adjuvant Alectinib in Patients With Resectable ALK-positive Non-small Cell Lung Cancer in the United States.

  2025cites this paper
• Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force

  2025cites this paper
• On the compounding manifestations of racism shaping the US HIV/AIDS epidemic: Why Ending the HIV Epidemic must address these factors for success.

  2025cites this paper
• Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure

  2025cites this paper
• Budget impact analysis of an integrated health and social care programme for Frail older persons

  2025cites this paper
• Comparing the Influence of Heterogeneity on Model Outcomes in Individual-Level and Cohort Simulations: An Exploratory Simulation Study.

  2025cites this paper
• Cost-utility evaluation of mammography screening program in Taiwan based on real-world data accounting for false positives.

  2025cites this paper
• Forecasting stroke and stroke-driven dementia in a rapidly ageing population: a model-based analysis of alternative projection scenarios for Ireland

  2025cites this paper
• Cost-Effectiveness of Applying Fluoride Varnish to Preschoolers in a Brazilian Scenario: An Economic Modelling Study.

  2025cites this paper
• Critical assessment of uncertainty in economic evaluations on influenza vaccines for the elderly population in Spain

  2025cites this paper
• Integrated models of nutrient dynamics in lake and reservoir watersheds: A systematic review and integrated modelling decision pathway

  2025cites this paper
• Beyond the Pill: Mapping Process-Oriented Decision Support Models in Pharmaceutical Policy

  2025cites this paper
• Critical Analysis of Markov Modeling for the Economic Evaluation of Obesity Interventions: A Systematic Review

  2025cites this paper
• A scoping review of the assessment reports of genetic or genomic tests reveals inconsistent consideration of key dimensions of clinical utility.

  2025cites this paper
• Application of decision analytic modelling to cardiovascular disease prevention in Sub-Saharan Africa: a systematic review

  2025cites this paper
• Can We Make Health Economic Decision Models as Simple as Possible, But Not Simpler? Introducing SMART tool

  2025cites this paper
• Estimating the potential public health and economic impact of vaccination strategies with an adapted vaccine in Colombia using a combined Markov-decision tree model

  2025cites this paper
• Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis

  2025cites this paper
• Holistic Impact of CKD: A Clinical, Economic, and Environmental Analysis by IMPACT CKD

  2025cites this paper
• Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis.

  2025cites this paper
• Health economics assessment of statin therapy initiation thresholds for atherosclerosis prevention in China: a cost-effectiveness analysis

  2025cites this paper
• Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force.

  2024cites this paper
• An Early-Stage Economic Evaluation of Superabsorbent Wound Dressings for the Management of Moderately to Highly Exuding Leg Ulcers in Slovakian Settings

  2024cites this paper
• Modeling the potential public health and economic impact of different COVID-19 vaccination strategies with an adapted vaccine in the Kingdom of Saudi Arabia

  2024cites this paper
• Early COVID-19 Pandemic Preparedness: Informing Public Health Interventions and Hospital Capacity Planning Through Participatory Hybrid Simulation Modeling

  2024cites this paper
• Using Chronic Kidney Disease as a Model Framework to Estimate Healthcare-Related Environmental Impact

  2024cites this paper
• In Silico Evaluation of Algorithm-Based Clinical Decision Support Systems: Protocol for a Scoping Review

  2024cites this paper
• IMPACT CKD: Holistic Disease Model Projecting 10-Year Population Burdens

  2024cites this paper
• Budget Impact Analysis of Implementing Antenatal Care Recommendations for Positive Pregnancy Outcomes at Public Primary Facilities in Tanzania

  2024cites this paper
• The cost-effectiveness of a co-managed care model for elderly hip fracture patients in China: a modelling study

  2024cites this paper
• Cost-effectiveness of drug consumption rooms in France: a modelling study

  2024cites this paper
• Modeling the potential public health and economic impact of different COVID-19 booster dose vaccination strategies with an adapted vaccine in the United Kingdom

  2024cites this paper
• Using Joint Longitudinal and Time-to-Event Models to Improve the Parameterization of Chronic Disease Microsimulation Models: an Application to Cardiovascular Disease

  2024cites this paper
• A Canadian Simulation Model for Major Depressive Disorder: Study Protocol

  2024cites this paper
• Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York Counties

  2024cites this paper
• Validation of a Model Estimating the Budget Impact of Video Capsule Endoscopy for Surveillance of Crohn’s Disease in an Italian Center

  2024cites this paper
• A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening

  2024cites this paper
• Introduction of the Capsules environment to support further growth of the SBGrid structural biology software collection

  2024cites this paper
• Cost-Utility Analysis of Maintenance Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Non-Small Cell Lung Cancer in Jordan.

  2024cites this paper
• National Recommendations for Pharmacoeconomic Evaluations Reporting for Reimbursement and Procurement of New Pharmaceutical Applications in Egypt

  2024cites this paper
• 'Managing values' in health economics modelling: Philosophical and practical considerations.

  2024cites this paper
• Cost-effectiveness of diagnostic imaging modalities in symptomatic patients with lower limb peripheral arterial disease: discrete event simulation model

  2024cites this paper
• Cost-utility evaluation of a health and social care integration programme for frail older adults in Argentina

  2024cites this paper
• Estimating the Lifetime Cost of Managing Hypertension in Ghana: A Modelling Study

  2024cites this paper
• The health equity implications of the Health Resources and Services Administration's Ryan White HIV/AIDS Program

  2024cites this paper
• Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model

  2024cites this paper
• The DEDUCE Model, A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation.

  2024cites this paper
• Projections of functional dependence among the late middle-aged and older population from 2018-2048 in China: a dynamic microsimulation

  2024cites this paper
• Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis.

  2024cites this paper
• Public health and economic impact of COVID-19 vaccination with the Pfizer-BioNTech COVID-19 Vaccine, KP.2, among adults in 2024/2025 in the United States

  2024cites this paper
• assertHE: an R package to improve quality assurance of HTA models

  2024cites this paper
• Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study

  2024cites this paper
• Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand

  2023cites this paper
• The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review

  2023cites this paper
• Toward best practices for economic evaluations of tumour-agnostic therapies: A review of current barriers and solutions.

  2023cites this paper
• Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation.

  2023cites this paper
• Long‐term benefits and harms of early colorectal cancer screening in German individuals with familial cancer risk

  2023cites this paper
• A multimorbidity model for estimating health outcomes from the syndemic of injection drug use and associated infections in the United States

  2023cites this paper
• Paediatric aortic valve replacement: a meta-analysis and microsimulation study

  2023cites this paper
• Predicting the long-term effects of electronic cigarette use on population health: a systematic review of modelling studies

  2023cites this paper
• Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations

  2023cites this paper
• The value of correctly diagnosing axial spondyloarthritis for patients and society.

  2023cites this paper
• Assessing needs-based supply of physicians: a criteria-led methodological review of international studies in high-resource settings

  2023cites this paper
• Modeled health economic and equity impact on dental caries and health outcomes from a 20% sugar sweetened beverages tax in Australia

  2023cites this paper
• A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R

  2023cites this paper